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Background: The bacterium Escherichia coli can be grown employing various carbohydrates as sole carbon and
energy source. Among them, glucose affords the highest growth rate. This sugar is nowadays widely employed as
raw material in industrial fermentations. When E. coli grows in a medium containing non-limiting concentrations of
glucose, a metabolic imbalance occurs whose main consequence is acetate secretion. The production of this toxic
organic acid reduces strain productivity and viability. Solutions to this problem include reducing glucose
concentration by substrate feeding strategies or the generation of mutant strains with impaired glucose import
capacity. In this work, a collection of E. coli strains with inactive genes encoding proteins involved in glucose
transport where generated to determine the effects of reduced glucose import capacity on growth rate, biomass
yield, acetate and production of an experimental plasmid DNA vaccine (pHN).
Results: A group of 15 isogenic derivatives of E. coli W3110 were generated with single and multiple deletions of
genes encoding glucose, mannose, beta-glucoside, maltose and N-acetylglucosamine components of the
phosphoenolpyruvate:sugar phosphotransferase system (PTS), as well as the galactose symporter and the Mgl
galactose/glucose ABC transporter. These strains were characterized by growing them in mineral salts medium
supplemented with 2.5 g/L glucose. Maximum specific rates of glucose consumption (qs) spanning from 1.33 to
0.32 g/g h were displayed by the group of mutants and W3110, which resulted in specific growth rates ranging
from 0.65-0.18 h-1. Acetate accumulation was reduced or abolished in cultures with all mutant strains. W3110 and
five selected mutant derivatives were transformed with pHN. A 3.2-fold increase in pHN yield on biomass was
observed in cultures of a mutant strain with deletion of genes encoding the glucose and mannose PTS
components, as well as Mgl.
Conclusions: The group of E. coli mutants generated in this study displayed a reduction or elimination of overflow
metabolism and a linear correlation between qs and the maximum specific growth rate as well as the acetate
production rate. By comparing DNA vaccine production parameters among some of these mutants, it was possible
to identify a near-optimal glucose import rate value for this particular application. The strains employed in this
study should be a useful resource for studying the effects of different predefined qs values on production capacity
for various biotechnological products.
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Biotechnological processes with Escherichia coli strains
modified for protein, DNA or metabolite production fre-
quently employ media containing glucose [1]. This carbo-
hydrate is widely utilized as a raw material since it is
relatively inexpensive and it is the preferred carbon and
energy source for E. coli and other industrial microorgan-
isms. In E. coli, glucose is internalized into the cytoplasm
by the phosphoenolpyruvate:sugar phosphotransferase sys-
tem (PTS). This is a complex protein system, widespread
in bacteria and absent in Archaea and eukaryotic organ-
isms [2]. PTS also participates in the transport and phos-
phorylation of other carbohydrates in addition to glucose.
This system is composed of the soluble and non sugar-
specific protein components enzyme I (EI) and the
phosphohistidine carrier protein (HPr) that relay a phos-
phoryl group from phosphoenolpyruvate (PEP) to the
sugar-specific enzymes IIA and IIB. PTS components IIC,
and in some cases also IID, constitute integral membrane
protein permeases that transports sugar molecules, which
are phosphorylated by component IIB (Figure 1). In E. coli,
21 different enzyme II complexes have been identified that
participate in import and phosphorylation of various car-
bohydrates [2]. Glucose is imported by the glucose en-
zyme II complex (IIGlc) that includes the IIAGlc enzyme
and the integral membrane permease IICBGlc [3]. The
mannose complex (IIMan) is composed of the IIABMan en-
zyme and the integral membrane permease IICDMan. It
has been reported that in addition to mannose, this PTS
complex can also transport glucose [4]. An E. coli mutant
strain with inactive glucose PTS complex still displaysFigure 1 Proteins involved in glucose transport and phosphorylation
IICBGlc, integral membrane glucose permease; IIABCBgl, components o
components of the mannose PTS complex; IIBCMal, components of th
N-acetylglucosamine PTS complex; GalP, galactose:H+ symporter; Mg
high-affinity ABC transporter; LamB, OmpF and OmpC, outer membragrowth on glucose with a rate corresponding to about 80%
of that observed in a wild type strain [5].
When E. coli grows under conditions of glucose limita-
tion, proteins normally involved in galactose transport
are induced and can also import glucose [6]. This
physiological response has also been observed in E. coli
strains with inactive PTS, even when growing in non-
limiting glucose concentrations [7]. One of the genes
induced under these conditions is galP, encoding the
galactose:H+ symporter GalP [8]. The genes mglABC,
encoding an ATP-binding protein, a galactose/glucose
periplasmic binding protein and an integral membrane
transporter protein, respectively, are also induced under
glucose limitation. These proteins constitute the high-
affinity ABC transporter Mgl system, involved in galact-
ose/glucose transport [6]. The enzyme glucokinase,
encoded by glk, catalyzes the ATP-dependent phosphor-
ylation of the glucose molecules internalized by GalP or
the Mgl system [9].
Under aerobic conditions when the glucose concentra-
tion in the medium is non-limiting, E. coli displays a high
rate of substrate consumption and a corresponding high
specific growth rate (μ). Under these conditions, E. coli se-
cretes the organic acid acetate [10,11]. This is the result of
a metabolic imbalance, also known as overflow metabol-
ism, where the rate of acetyl-coenzyme A (AcCoA) syn-
thesis surpasses the capacity of the tricarboxylic acid
(TCA) cycle to completely consume this metabolite.
Therefore, the amount of AcCoA not consumed by the
TCA cycle is diverted into the phosphotransacetylase
(Pta)-acetate kinase (Ack) pathway where acetate isin E. coli. EI, enzyme I; HPr, phosphohistidine carrier protein;
f the beta-glucoside PTS complex; IIABMan and IICDMan
e maltose PTS complex; IIABCNag, components of the
lA, MglB and MglC, components of the galactose/glucose
ne proteins.
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ate synthesis by the Pta-Ack pathway and its assimilation
by AcCoA synthethase (Acs), constitute a futile cycle that
maintains a physiological level of the regulatory metabolite
acetyl-phosphate. A shift towards acetate accumulation
occurs as a result of carbon catabolite repression of Acs
expression under conditions of high glucose import rates
[13,14]. Acetate production is a problem since this consti-
tutes the loss of precursor molecule AcCoA. In addition,
acetate is a toxic organic acid whose accumulation in cul-
ture media reduces productivity [15]. Solutions to this
problem involve glucose feeding strategies to maintain a
low concentration of this sugar in culture medium and
also the generation of mutant strains with impaired acet-
ate biosynthesis capacity [16,17]. In addition, mutant
strains with reduced glucose import capacity have been
generated with the purpose of decreasing acetate produc-
tion. Inactivation of gene ptsG, encoding IICBGlc, resulted
in a significant reduction of acetate secretion with a con-
comitant increase in production of a recombinant protein
[5]. The complete inactivation of PTS by deletion of the
ptsHI-crr operon encoding EI, HPr and IIAGlc combined
with the chromosomal overexpression of gene galP, en-
coding a non-PTS glucose importer, resulted in a strain
displaying a PTS– Glc+ phenotype, a lower rate of acetate
production and a higher capacity for recombinant protein
production [18].
One of the biotechnological products synthesized now-
adays by recombinant E. coli is plasmid DNA (pDNA),
which can be used as an alternative for gene therapy and
immunization in various therapeutic applications [19].
Since plasmid titer is directly related to biomass forma-
tion, fermentation strategies for pDNA production are
based on increasing cellular density. However, as stated
above, acetate production can be an important drawback
in this type of cultures. Some of the strategies employed to
reduce acetate production in E. coli have been applied to
pDNA production, with various degrees of success
[19-21]. In the case of PTS modification, the use of a
strain with a PTS– Glc+ phenotype and reduced qs,
resulted in increased production of pDNA [20].
The above examples illustrate how a qs reduction in E.
coli can have a positive effect on strain performance for
the production of recombinant proteins and pDNA.
However, previous works have focused on generating
and studying either one or a few mutant strains with al-
tered qs. It remains to be determined what would be the
physiological and production performance effects of al-
tering qs over a wide range of values in a group of iso-
genic strains. With this purpose, a collection of E. coli
mutants was generated with mutations in transporter
proteins involved in glucose import. This group of 15
mutants and wild type W3110 span a qs range from 1.33
to 0.32 g/g h, enabling a comparative study of theconsequences of altering, within predetermined values,
the glucose import capacity on key physiological param-
eters and the capacity to produce pDNA.
Methods
Strains and plasmids
The strains used in this work are described in Table 1.
The reference strain E. coli W3110 is a derivative of E. coli
K-12 [22]. Mutant derivatives of W3110 were constructed
by P1 transduction, chromosomal gene inactivation em-
ploying PCR products or a combination of both methods
[23]. Table 1 indicates the donor strains from the Keio col-
lection that were employed as donors for P1 transduction
experiments and the names of the oligonucleotides
employed for PCR product gene inactivation [24]. To gen-
erate strains with more than one mutation, the gene en-
coding for kanamycin (Kan) resistance was excised
employing plasmid pCP20 that expresses recombinase
FLP [23]. Verification of the desired genotypes was made
by PCR employing pairs of primers as follows: ptsG, ptsGF
and ptsGR; manX, manXF and ManXR; malX, MalXF and
MalXR; bflF, bglFF and bglFR; nagE, nagEF and nagER;
glK, glk2F and glk2R; galP, galPF and galPR; mglABC,
mglABF and mglABR; ptsHIcrr, PTSF and PTSR. Plasmid
pcDNAHN176-construct (pHN) is an experimental vaccine
against mumps. It contains the pUC origin of replication,
an ampicillin resistance gene and a viral haemagglutinin-
neuraminidase gene cloned under transcriptional con-
trol of the cytomegalovirus promoter [25].
Growth media and cultivation conditions
The medium used during mutant strains construction
and selection was Luria-Bertani (LB) with the corre-
sponding antibiotic: chloramphenicol (Cm) 10 μg/mL,
Km 10 μg/ml and carbenicilin (Cb) 100μg/mL. For shake
flask cultures M9 mineral medium was used, containing
2.5 g/L glucose, 6 g/L Na2HPO4, 0.5 g/L NaCl, 3 g/L
KH2PO4, 1 g/L NH4Cl, 0.5 g/L MgSO4•7H2O 0.01 g/L
CaCl2 and 0.01 g/L thiamine hydrochloride. Cultures
with strains for pHN production were performed in
shake flasks with PD medium containing 2.5 g/L glu-
cose, 17 g/L K2HPO4, 5.3 g/L KH2PO4, 2.5 g/L (NH4)
2SO4, 1 g/L (NH4)Cl, 1 g/L sodium citrate, 1 g/L
MgSO4 · 7H2O, 0.01 g/L thiamine hydrochloride and 2
mL of a stock solution of trace elements [20]. Glucose
and salts solution were sterilized separately at 121°C
during 20 minutes. All stock cultures were stored at −70°
C in LB medium containing glycerol (40% v/v). The
inoculum for shake flasks cultures consisted of 5 ml
from LB overnight cultures that were sub-cultured in
shake flasks containing 50 ml of M9 or PD medium with
2.5 g/L glucose starting with an OD600nm = 0.1 and incu-
bated at 37°C, 300 rpm in an orbital shaker until an OD
of 2.0 was reached, then, a sample was used to inoculate
Table 1 E. coli strains and plasmid employed in this study
Name Description Source or construction method*
Strains
JW1087-2 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, ΔptsG763::kan, rph-1,Δ(rhaD-rhaB)568, hsdR514 [23]
JW1806-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, ΔmanX741::kan, rph-1,Δ(rhaD-rhaB)568, hsdR514 [23]
JW1613-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, ΔmalX769::kan, rph-1,Δ(rhaD-rhaB)568, hsdR514 [23]
JW3700-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, ΔbglF753::kan,Δ(rhaD-rhaB)568, hsdR514 [23]
JW0665-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), ΔnagE728::kan, λ-, rph-1,Δ(rhaD-rhaB)568, hsdR514 [23]
JW2910-1 F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3), λ-, ΔgalP789::kan, rph-1,Δ(rhaD-rhaB)568, hsdR514 [23]
W3110 F- λ- rph-1 IN(rrnD-rrnE)1 [23]
WG W3110 ΔptsG::FRT-Km-FRT This study JW1087-2
WGX WG ΔmalX::FRT-Km-FRT This study JW1613-1
WGB WG ΔbglF::FRT-Km-FRT This study JW3700-1
WGE WG ΔnagE::FRT-Km-FRT This study JW0665-1
WGM WG ΔmanX::FRT-Km-FRT This study JW1806-1
WGMX WGM ΔmalX::FRT-Km-FRT This study JW1613-1
WGMB WGM ΔbglF::Km; FRT-Km-FRT This study JW3700-1
WGME WGM ΔnagE::FRT-Km-FRT This study JW0665-1
WGP WG ΔgalP::FRT-Km-FRT This study JW2910-1
WGC WG ΔmglABC::FRT-Cm-FRT This study mglABCDtF, mglABCDtR
WGMP WGM ΔgalP::FRT-Km-FRT This study JW2910-1
WGMC WGM, ΔmglABC::FRT-Cm-FRT This study mglABCDtF, mglABCDtR
WHI W3110 ΔptsHIcrr::FRT-Cm-FRT This study PTSDF PTSDR
WHIP WHI ΔgalP::FRT-Km-FRT This study JW2910-1
WHIC WHI ΔmglABC::FRT-Cm-FRT This study mglABCDtF, mglABCDtR
W3110p W3110/pHN This study
WGp WG/pHN This study
WGMCp WGMAB/pHN This study
WGMp WGM/pHN This study
WGMEp WGME/pHN This study
WHICp WHIAB/pHN This study
Plasmids
pHN Derivative of pcDNA3.1 with cloned gene encoding for a 567 nucleotide region from
the HN gene
[25]
pKD3 bla, FRT-Cm-FRT [23]
pKD46 bla, γ β exo (red recombinase), temperature-conditional replicon [23]
pCP20 bla, flp, temperature-conditional replicon [23]
Primers
ptsGF CGC AGG TAA CCA CCG ATA AC This study
ptsGR GCA ACG CGC TAT ATT GCA GA This study
manXF ATC TGG CAC GTT GAC GTG TT This study
manXR TTG CCG TTA TCA GCA GCC TT This study
malXF AGC CAT GCA GAT GAC CTA CT This study
malXR AAC GGT CAG CGA CAT AAT CC This study
bglFF GGA TTG TTA CCG CAC TAA GC This study
bglFR AGG CAC CTT CCA CCT GAT TG This study
nagEF CGT TGG CGG ATT AGG CAT CT This study
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Table 1 E. coli strains and plasmid employed in this study (Continued)
nagER TGT TGG ATG CGA CGC TCA AG This study
glk2F CCG CCA GCA AGA CCG AGA AT This study
glk2R TCT ACC GCC GCT TCT TCC AG This study
galPF CGA TGC TGC CGG TCT GAA GT This study
galPR GTG TTG CGA CGC ACG GAT TG This study
PTSF CGA TGT GGC GGT AAC AAT CT This study
PTSR CCG CTT CAT AGC AGG TAT GT This study
mglABF GCT TCG GCG TTC AGT AAC AC This study
mglABR TAT GAC CGA ATG CGG ACC AC This study
PTSDF CTA GAC TTT AGT TCC ACA ACA CTA AAC CTA TAA GTT GGG GAA ATA CAA TGG TGT
AGG CTG GAG CTG CTT C
This study
PTSDR ATG GGC GCC ATT TTT CAC TGC GGC AAG AAT TAC TTC TTG ATG CGG ATA ACA TGG
GAA TTA GCC ATG GTC C
This study
mglABCDtF AGC ATT TAT CTC AAG CAC TAC CCT GCA TAA GAA AAA CCG GAG ATA CCA TGG TGT
AGG CTG GAG CTG CTT C
This study
mglABCDtR TTT ATG ACC GAA TGC GGA CCA CAT TCA CAT CAT TTC TTA CGC GCG TAT TTA TGG
GAA TTA GCC ATG GTC C
This study
*The donor strain employed in P1 transduction or the names of the oligonucleotides employed for gene inactivation with PCR products are indicated.
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Samples for analysis were taken periodically. The
OD600nm was determined and cells were centrifuged
(13,000 g for 5 min) and the supernatant used for glu-
cose and acetate determination by HPLC. In cultures for
pHN production, an additional sample was taken to de-
termine plasmid DNA concentration. The employed
OD600nm and cell dry mass (CDM) (g/L) correlation was
CDM= 0.45 x OD600nm [26].
Determination of glucose, acetic acid and plasmid
concentration
The concentration of D-glucose and organic acids was
determined employing an Aminex HPX-87H column
(300 X 7.8 mm; 9 Am Bio-Rad, Hercules, CA). Separ-
ation was carried out isocratically with 5 mM H2SO4 at
a flow rate of 0.5 mL/min and a temperature of 50°C.
Under these conditions glucose was detected by refrac-
tion index and acetic acid by photodiode array at 210
nm. For these measurements a Waters HPLC system
was used: 600E quaternary pump, 717 automatic in-
jector, 2410 refraction index, and 996 photodiode array.
pHN concentration was determined by extracting plas-
mid DNA with the Qiagen Spin Mini Prep kit (Hilden,
Germany), following manufacturer instructions. The
plasmid DNA concentration was determined at 260 nm
using a Nanodrop UV spectrophotometer [27].
Kinetic parameters calculation
For the characterization of the strains used in this work,
maximum specific rates of growth (μ), glucose consump-
tion (qs), acetate production (qac), pHN plasmid produc-
tion (qp), yield of biomass on glucose (YX/S), yield ofacetate on glucose (Yac/S), yield of acetate on biomass
(Yac/X), yield of plasmid on glucose (YP/S) and yield of
plasmid on biomass (YP/X) were determined. Yield
values were calculated using linear regression of product
concentration versus substrate or biomass concentration
during the exponential growth phase. The linear least
squares fit to the data displayed R2 values equal or
higher than 0.97.
Values for qs, qac, and qp were calculated employing
the following equations:
qs ¼ mμ=Yxs
qac ¼ Yac=X  μ
qp ¼ YP=X  μ
These parameters were calculated during exponential
growth phase. Flask cultures were performed in triplicate
and the values reported represent the mean of all
experiments.
Results and discussion
Generation and characterization of E. coli mutant strains
lacking proteins involved in glucose import
The aim of this study was to generate and characterize a
group of mutants derived from strain W3110, displaying a
wide range of qs values. The strategy followed to progres-
sively decrease glucose import capacity consisted on in-
activating genes encoding PTS components and non-PTS
transport proteins. Under the growth conditions employed
in this study (glucose 2.5 g/L), it can be expected that glu-
cose is transported by the PTS, since the KM of IICB
Glc for
this sugar is 3 to 10 μM (0.6 to 18 mg/L) [3]. Therefore,
mutants with inactive IICBGlc and other PTS components
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that IICDMan can transport glucose in a strain lacking
IICBGlc activity [4]. However, it is not known which of the
other remaining PTS complexes could be involved in glu-
cose transport in the absence of IICBGlc or in a double
mutant lacking both IICBGlc and IICDMan components. In
this study, we chose to inactivate selected components
from the glucose and mannose PTS families, assuming
they would show specificity towards glucose as substrate
since both, IICBGlc and IICDMan, can transport this sugar.
Since the number of PTS complexes belonging to these
two families is rather large, only a few members were arbi-
trarily selected for inactivation. Single, double and triple
mutant derivatives of W3110 were constructed including
genes encoding transport proteins from the glucose
(ptsG), mannose, (manX), beta-glucoside (bglF), maltose
(malX) and N-acetylglucosamine (nagE) PTS complexes.
Inactivation of ptsG (strain WG) caused a 21%, 22% and
63% reduction in qs, μ and qac, respectively (Table 2 and
Additional file 1: Figure S1). This is expected since IICBGlc
is the main glucose importer under the studied conditions.
However, these results also show that there is still signifi-
cant remaining glucose import capacity in the mutant
strain; therefore, other transport proteins are involved in
this process. To generate mutant derivatives of strain WG
with further reduced qs, genes encoding specific compo-
nents of the above-mentioned PTS complexes were
inactivated. In the ptsG- background, inactivation of malX
(strain WGX), nagE (strain WGE) or manX (strain WGM)
caused a further reduction in qs and μ. Furthermore, no
acetate was detected in the supernatants of cultures with
these three strains, indicating the elimination of overflowTable 2 Kinetic and stoichiometric parameters of wild type an
Strains Deleted gene(s) μ (h-1)
W3110 - 0.65 ± 0.02
WG ptsG 0.51 ± 0.01
WGX ptsG, malX 0.23 ± 0.03
WGB ptsG, bglF 0.43 ± 0.04
WGE ptsG, nagE 0.41 ± 0.02
WGM ptsG, manX 0.36 ± 0.03
WGMX ptsG, manX, malX 0.32 ± 0.01
WGMB ptsG, manX, bglF 0.29 ± 0.00
WGME ptsG, manX, nagE 0.28 ± 0.02
WGP ptsG, galP 0.49 ± 0.08
WGC ptsG, mglABC 0.48 ± 0.01
WGMP ptsG, manX, galP 0.29 ± 0.01
WGMC ptsG, manX, mglABC 0.31 ± 0.01
WHI ptsHIcrr 0.25 ± 0.01
WHIP ptsHIcrr, galP 0.18 ± 0.02
WHIC ptsHIcrr, mglABC 0.20 ± 0.01metabolism (Additional file 1: Figure S1). In contrast, in-
activation of ptsG and bglF (strain WGB) did not decrease
qs, when compared to strain WG. These results indicate
that mannose, maltose and N-acetylglucosamine PTS
complexes contribute to glucose import in the absence of
IICBGlc. From strain WGM, mutant derivatives were gen-
erated to determine if beta-glucoside, maltose or N-
acetylglucosamine PTS complexes participate in glucose
transport in this genetic background. From these mutant
strains, only WGME showed a reduction in qs and μ of
58% and 57%, respectively, when compared to W3110.
Previous results indicated that strain WGME displays
growth on glucose even after the inactivation of several
transport proteins. Glucose transport in this strain could
be dependent on both PTS and non-PTS transport pro-
teins. To determine the extent of the contribution to
glucose transport of the still-active PTS complexes in
strain WGME, a mutant derivative of W3110 was gener-
ated by deletion of the ptsHI, -crr operon (strain WHI).
Deletion of genes encoding EI and HPr disrupts the
phosphotransfer chain, thus rendering all PTS com-
plexes inactive. As expected, the complete elimination of
PTS activity caused a severe reduction in qs and μ of
64% and 62%, respectively, when compared to W3110.
When compared to WGME, strain WHI showed 12%
and 14% reduction in μ and qs, respectively. These re-
sults suggest that approximately 14% of the glucose im-
port capacity in WGME is dependent on one or several
of the still active PTS complexes in this strain, and the
remaining capacity is dependent on non-PTS trans-
porters. However, this conclusion should be taken with
caution, since PTS is involved in regulatory processesd mutant strains lacking various glucose transporters
qs (g/g h) qac (g/g h) YX/S
1.33 ± 0.04 0.19 ± 0.02 0.49 ± 0.00
1.05 ± 0.12 0.07 ± 0.05 0.53 ± 0.12
0.51 ± 0.01 0 0.41 ± 0.01
1.06 ± 0.03 0.06 ± 0.02 0.42 ± 0.03
0.69 ± 0.06 0 0.60 ± 0.08
0.65 ± 0.05 0 0.56 ± 0.08
0.58 ± 0.06 0 0.55 ± 0.06
0.66 ± 0.07 0 0.40 ± 0.02
0.56 ± 0.00 0 0.48 ± 0.03
1.19 ± 0.00 0.06 ± 0.00 0.44 ± 0.01
1.02 ± 0.00 0.08 ± 0.00 0.47 ± 0.05
0.56 ± 0.01 0 0.52 ± 0.02
0.68 ± 0.00 0 0.47 ± 0.01
0.49 ± 0.03 0 0.51 ± 0.02
0.32 ± 0.02 0 0.55 ± 0.03
0.32 ± 0.02 0 0.38 ± 0.05
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Therefore, it cannot be ruled out that altered regulatory
responses on genes encoding non-PTS transporters
could occur in strain WHI, when compared to WGME.
The transporter GalP and the Mgl protein system are
known to participate in glucose import under conditions
of glucose starvation. Even though the culture medium
employed in this study contains a non-limiting glucose
concentration, as a result of the inactivation of glucose
importers, a low intracellular level of glucose-6-phos-
phate and other central metabolism intermediates could
be expected in the mutant strains displaying low qs
values. To determine if GalP or Mgl are involved in glu-
cose transport in some of these strains, derivatives lack-
ing either one of these two importers were generated
from WG and WGM. Strains WGP and WGC showed
similar qs and μ values as progenitor strain WG, indicat-
ing that GalP or Mgl do not contribute to glucose im-
port in this genetic background. Whereas in the WGM
background, strain WGMC did not show a change in
glucose import capacity, while mutant WGMP displayed
a decrease in qs and μ. These results show that only after
the qs decreases to a value close to 0.65 g/g h, then a
contribution of GalP to glucose import can be detected.
To determine the involvement of non-PTS transporters
on glucose import capacity in strain WHI, derivatives
with inactive galP (WHIP) or mglABC (WHIC) were
generated and characterized. Both mutants displayed a
35% reduction in qs when compared to progenitor WHI.
These results indicate that both GalP and the Mgl sys-
tem contribute to glucose import in the strain lacking
functional PTS.
When comparing the YX/S values among wild type and
mutant strains, minimal differences were detected. The
group of strains characterized in this study, including
wild-type W3110, display a wide range of qs, μ and qac
values. Under the conditions employed here, μFigure 2 Specific growth rate as a function of the specific glucose
uptake rate for various E. coli strains generated in this study.correlated linearly with qs (R
2 = 0.92) (Figure 2). This re-
sult is consistent with the small differences in YX/S
among strains. As result of the distinct qs values
displayed by these strains, the amount of time taken to
completely consume the 2.5 g/L of glucose in the culture
medium varied from 6 to 28 h (Additional file 1: Figure S1).
In addition to the physiological effects of such glucose con-
sumption rates, these differences would be expected to have
an impact on strain production capacity, mainly specific
productivity, for various biotechnological products, as will
be discussed below.
When considering data from the five strains that accu-
mulated acetate in the medium (W3110, WG, WGB, WGP
and WGC) and WGE, the mutant strain with the highest
qs and μ values that did not produce acetate, it was found
that qac correlated linearly with μ (R
2 = 0.91) (Figure 3). It
is not possible to ascertain if the observed correlation is
maintained at μ values lower than 0.43 h-1 (strain WGB),
nevertheless, linear regression analysis of this data was
employed to calculate μ = 0.39 h-1 as the value correspond-
ing to a qac= 0. This value is close to a μ of 0.375 h
-1, that
was determined from glucose-limited continuous cultures
with E. coli K-12 TG1, as the lowest value where acetate
was detected [29]. A study employing accelerostat cultiva-
tions with strain MG1655 identified a two-phase acetate
accumulation pattern [13]. The slow rate acetate accumu-
lation phase started at a μ of 0.27 h-1, whereas high rate
acetate accumulation was detected at a μ of 0.46 h-1. As-
suming a similar physiological response between strains
MG1655 and W3110, it is possible that acetate accumula-
tion in this study with mutant derivatives was detected
until the high rate production phase was reached. Further
detailed analyses, employing accelerostat or chemostat cul-
tivations, should allow determination of the specific acetate
accumulation pattern for each mutant strain.
The qualitative effects on qs and μ of deleting specific






Figure 3 Specific acetate production rate as a function of the
specific growth rate for various E. coli strains generated in
this study.
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of E. coli strains MG1655 and AF1000 having some of
the same gene deletions performed in this study [30-32].
However, the magnitude of qs reduction as function of
specific gene inactivation differs from our results. This
can be explained considering that different culture
media was employed and the strains genetic back-
grounds are not identical.
Generation and characterization of strains with modified
glucose import capacity for the production of a DNA
vaccine
The characterization of the strains generated in this study
enabled the identification of mutant derivatives of W3110
with distinct qs, and qac values. In several of these strains,
acetate production was reduced or absent. Lower acetate
production and accumulation is associated with an in-
creased capacity for pDNA production in E. coli cultures
[19,20]. To determine the effect of different qs, qac and μ
values on pDNA production capacity, some of the strains
generated in this study were transformed with plasmid
pHN. Strains W3110, WG, WGM, WGME, WGMC,
WHI and WHIC were transformed with plasmid pHN to
generate recombinant strains W3110p, WGp, WGMp,
WGMEp, WGMCp, WHIp and WHICp, respectively.
These strains were grown in shake-flask cultures with PD
medium supplemented with 2.5 g/L glucose. This culture
medium has been employed previously for pDNA produc-
tion studies; therefore, it was used here to facilitate strain
performance comparisons. During strain characterization,
it was determined that strain WHIp did not grow in PD
medium; therefore, it was not considered for further ana-
lysis. Table 3 summarizes the kinetic and stoichiometric
parameters of the six remaining strains. Among these
strains, acetate was detected only in cultures with W3110
(0.4 g/L) (Additional file 2: Figure S2). The maximumTable 3 Kinetic and stoichiometric parameters of wild type an





1.14 ± 0.15 1.42 ± 0.02 0.82 ± 0.30
Maximum plasmid pHN
concentration (mg/L)
0.83 ± 0.18 1.06 ± 0.19 1.63 ± 0.45
Maximum acetate
concentration (g/L)
0.40 ± 0.01 0 0
μ (h-1) 0.63 ± 0.04 0.49 ± 0.00 0.33 ± 0.06
YP/S (mg/g) 0.43 ± 0.15 0.54 ± 0.10 1.03 ± 0.01
YP/X (mg/g) 0.65 ± 0.04 0.93 ± 0.14 2.10 ± 0.30
qs (g/g h) 1.20 ± 0.07 0.89 ± 0.07 0.70 ± 0.09
qp (g/g h) 0.50 ± 0.09 0.43 ± 0.02 0.53 ± 0.09
Culture time(h) 5 7 9pHN titer level varied among strains, with WGMCp
displaying the highest value. The same trend was observed
for plasmid yield from glucose (YP/S) or from biomass (YP/
X). The highest plasmid specific productivity was observed
for strain WGMCp and also for WGMp. Figure 4 shows
the YP/X as a function of qs for the pHN producing strains.
Compared to strain W3110p, the YP/X for strains WGp
and WGMCp were 1.4 and 3.2-fold higher, respectively. In
the case of strain WGp, the observed increase can be
explained by the lack of acetate production, when com-
pared to W3110p. A similar result has been reported when
comparing wild type and mutants defective in glucose
transport in the case of recombinant protein production
[18,31,33]. The final acetate titer in cultures with W3110p
was not high enough to expect a toxic effect [15]. There-
fore, the increase in pHN production in strain WGp can
be attributed mainly to the elimination of overflow metab-
olism, resulting in a more efficient use of the carbon
source. However, the higher YP/X observed for WGMCp,
when compared to WGp, cannot be explained by lower
acetate production, since this metabolite was not detected
in culture supernatants of either strain. Alterations to glu-
cose consumption, either by the inactivation of glucose
importers or feeding strategies to limit this nutrient, have
been known to alter central carbon metabolism fluxes
[26,34]. It can be speculated that metabolic flux distribu-
tion in WGMCp favors the synthesis of DNA precursors,
leading to higher pHN production. A more detailed com-
parative analysis of these strains, including fluxome and
other “omics” approaches should allow a better under-
standing of the observed results.
A recent study has determined pHN plasmid product-
ivity with strain DH5α, a high-performance plasmid pro-
duction strain, under culture conditions similar to those
employed here. This report revealed an YP/X of 6.56 ±
0.17 mg/g and a qp of 2.59 ± 0.12 (g/g h) for pHN [27].d mutant strains transformed with plasmid pHN
WGMp WGMEp WHICp
(ΔptsG, ΔmanX) (ΔptsG, ΔmanX, ΔnagE) (ΔptsHIcrr, ΔmglABC)
1.08 ± 0.05 1.12 ± 0.06 1.13 ± 0.16
1.09 ± 0.34 1.19 ± 0.41 1.47 ± 0.30
0 0 0
0.33 ± 0.02 0.37 ± 0.01 0.14 ± 0.02
0.89 ± 0.00 0.75 ± 0.05 0.84 ± 0.04
1.57 ± 0.14 1.39 ± 0.09 1.08 ± 0.13
0.59 ± 0.03 0.57 ± 0.03 0.31 ± 0.07








Figure 4 Plasmid pHN yield from biomass as a function of the
specific glucose uptake rate for various E. coli strains generated
in this study.
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YP/X and qp, respectively, when compared to results with
strain WGMCp. It should be pointed out, though, that
strain DH5α bears several mutations that have the effect
of increasing plasmid yield and productivity. It can be
expected that these mutations would also increase plas-
mid production capacity in strain WGMCp, although
the magnitude of such improvement cannot be esti-
mated and would have to be determined experimentally.
Compared to WGMCp, strains with progressively lower
qs, WGMp, WGMEp and WHICp displayed a lower YP/X.
It can be assumed that a low glucose consumption rate
should cause a limitation of central carbon metabolism pre-
cursors and energy, having a negative impact on pHN
production. A similar result has been reported when com-
paring two mutant strains for the production of a recom-
binant protein. A ΔptsG ΔmanX mutant produced less
acetate than a ΔptsGmutant, but unexpectedly, also less re-
combinant protein [33]. In this case, the authors point out
that not only is low acetate production important for strain
performance, but also an adequate cellular energy status.
The control of plasmid replication is a complex process
influenced by the cell physiologic state. Growth rate is one
of the parameters that have an impact on plasmid copy
number. For plasmids having a pUC origin of replication,
such as pHN, a higher copy number is observed when
comparing slow to fast growing cells [35]. It has been gen-
erally accepted that plasmid copy number in inversely pro-
portional to the growth rate [19]. By altering glucose
import capacity in the studied strains, cellular parameters
such as qs, qac and μ μ were simultaneously modified. All
of these parameters influence pHN cellular content. The
qs and μ displayed by strain WGMCp would represent op-
timal or near-optimal values for pHN production under
the studied conditions which supports the idea that there
should be an optimal flux distribution for pDNAsynthesis, and that it may be reached not necessarily at
very low growth rates. The physiologic state in this strain
would be favorable for pHN production by having a rela-
tively low μ that increases plasmid content and sufficient
glucose import capacity to avoid carbon and energy limita-
tion. When compared to WGMCp, strains WGMp,
WGMEp and WHICp, have lower qs. Therefore, it is likely
that these strains are energy and carbon-limited, and this
state limits plasmid production capacity. A low energy
state, resulting from a very low qs might also explain why
strain WHI, when transformed with pHN, did not display
growth in minimal medium. This is likely the result of in-
capacity to cope with the additional demand for precur-
sors and energy required for plasmid replication.
Previous publications have demonstrated an increased
capacity for plasmid or recombinant protein production
in strains having reduced glucose import capacity. How-
ever, in these reports only a few mutant strains were
characterized. Therefore, only a small fraction of the po-
tential phenotypic space was sampled. In contrast, in this
study, a group of mutants was generated, covering a
wide range of glucose import capacity in relatively small
steps. By employing this collection of mutants, it was
possible to identify a near-optimal glucose import rate
for plasmid production capacity under the employed
conditions. This qs value is associated to a physiological
state were no overflow metabolism is present and the
rate of glucose import still provides sufficient energy
and metabolic precursors for cell growth requirements
plus the burden of plasmid replication. To our know-
ledge, there is still no theoretical method to predict such
a qs value, therefore, a combinatorial approach, like the
one employed here, should be useful for correlating glu-
cose consumption rate to several physiological and pro-
duction parameters.
Conclusions
A group of mutants with modified glucose import capacity
was derived from E. coli W3110, a robust strain that has
been employed as production host for various biotechno-
logical products. This group of mutants affords a large de-
gree of phenotypic diversity that can be explored when
searching for specific genotypes leading to improved
production capacity. The mutant strains generated and
characterized here were employed in experiments for de-
termining the correlation of distinct qs values to specific
physiological and pDNA vaccine production parameters.
Although similar data could be obtained by employing
chemostat cultures, the use of mutant strains with modi-
fied glucose import capacity should simplify subsequent
production processes by enabling constant glucose con-
sumption rates in batch cultures.
The characterization of a subset of the generated mu-
tants allowed the identification of a near-optimal qs
Fuentes et al. Microbial Cell Factories 2013, 12:42 Page 10 of 11
http://www.microbialcellfactories.com/content/12/1/42value for pHN production. A similar approach can be
followed, employing this mutant collection, to identify
phenotype(s) leading to the best production parameters
for other products such as recombinant proteins.
Additional files
Additional file 1: Figure S1. Growth profile of W3110 and mutant
derivatives in shake flask cultures. Glucose concentration (red squares),
biomass concentration (blue circles), acetate concentration (green
triangles). A. W3110, B. WG, C. WGX, D. WGB, E. WGE, F. WGM, G. WGMX,
H. WGMB, I. WGME, J. WGP, K. WGC, L. WGMP, M. WGMC, N. WHI, O.
WHIP, P. WHIC.
Additional file 2: Figure S2. Growth profile of W3110 and mutant
derivatives transformed with plasmid pHN in shake flask cultures. Glucose
concentration (red squares), biomass concentration (blue circles), acetate
concentration (green triangles). A. W3110p, B. WGp, C. WGMCp, D.
WGMEp, E. WGMp, F. WHICp.
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